Katie (Romberg) Blatt is currently the Vice President of Clinical Operations Oncology at Immunocore, a position held since 2023. Previously, Katie held various roles at Immunocore, including Associate Director and Director of Asset Lead, from 2018 to 2021. Katie's earlier experience includes positions as a Clinical Program Coordinator at Cephalon, and various roles in clinical project management at companies such as Teva Pharmaceuticals, Wyeth, and MDS Pharma Services. Katie earned education from Pennsylvania State University between 1999 and 2002.
This person is not in the org chart
This person is not in any teams
This person is not in any offices